Scurrula parasitica
What's the taxonomical classification of Scurrula parasitica?
Scurrula parasitica belongs to the kingdom Plantae and is classified within the phylum Streptophyta. At the class level, it is categorized as Equisetopsida, falling under the subclass Magnoliidae. Its taxonomic lineage continues through the order Santalales and the family Loranthaceae. Finally, the plant is identified by its specific genus, Scurrula, and its unique species designation, parasitica.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Santalales |
| Family | Loranthaceae |
| Genus | Scurrula |
| Species | parasitica |
What are the morphological characteristics of this plant?
Scurrula parasitica has scale-like, imbricate leaves that are small, linear, and arranged in a decussate pattern along its woody, parasitic stems. The plant lacks true roots, instead utilizing a specialized haustorium to extract nutrients and water from its host trees. Its flowers are typically small and inconspicuous, often appearing in axillary clusters. The fruit is characterized by a small, somewhat fleshy nutlet enclosed within a dry, woody capsule. This mistletoe species exhibits a compact, bushy growth habit that conforms to the branches of its host.
What is the geographical distribution of this plant?
This plant is native to the tropical and subtropical regions of Southeast Asia, including parts of India, China, Myanmar, Thailand, Malaysia, and Indonesia. Its distribution is primarily centered within the moist evergreen forests of these equatorial territories. It thrives in areas where host trees are abundant to support its hemiparasitic lifestyle. The species is frequently found at various elevations depending on the local climate and forest type. This specific range allows it to colonize diverse ecosystems across the Indomalayan realm.
How is this plant cultivated?
This plant is a hemiparasitic mistletoe that must be cultivated by attaching its roots directly to the living branches of a suitable host tree.
Because it derives much of its water and nutrients from the host, it cannot be grown in standard soil alone. Cultivators must select a compatible host species to ensure the parasite successfully penetrates the cambium layer. Once established, the plant requires bright, filtered sunlight and consistent humidity to mimic its natural canopy environment.
Proper care involves monitoring the health of the host tree to prevent the parasite from killing its support system.
What parts of this plant are used medicinally?
This plant Scurrula parasitica is used medicinally primarily through its leaves. These leaves are often prepared as a decoction or a paste to treat various ailments. They are frequently applied topically to soothe skin irritations or swallowed to address internal issues. Some traditional practices also involve using the leaf extracts to manage fever or digestive discomfort. The medicinal potency of the leaf makes it the most significant part of the plant for local healers.
According to a study published by "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", Scurrula parasiticus polysaccharides are isolated from the leaf of the plant using water extraction and ethanol precipitation. These polysaccharides can inhibit the growth of sarcoma S180 in mice when administered at a dose of 100 mg x kg(-1) x d(-1). This specific dose was found to be the optimal amount for inhibiting S180 growth, resulting in a tumor inhibition rate of 54%. The mechanism involves down-regulating the expression of Ki-67, Cyclin D1, and Bcl-2 proteins while up-regulating the expression of the Bax protein. These actions indicate that the plant part helps inhibit cancer cell proliferation and promote cancer cell apoptosis in vivo.
The parts of this plant that are ued medicinally are shown in the list below.
- leaf
What traditional systems uses this plant?
This plant, Scurrula parasitica, is traditionally utilized in various ethnomedical practices across Southeast Asia and India to treat diverse ailments.
Local healers often employ the leaves and stems to manage inflammatory conditions and skin disorders. In some regional traditions, decoctions made from the plant are consumed to alleviate digestive issues or fever. The species is frequently categorized as a parasitic mistletoe, and its biological properties are integrated into folk remedies for systemic wellness.
These historical applications rely on the plant's specific phytochemical profile to address local health concerns.
What are the pharmacological activities of Scurrula parasitica?
This plant has anti-cancer, anti-tumor, antioxidant, and cytotoxic pharmacological activities that make it a subject of significant medicinal interest. Its antioxidant properties allow it to neutralize free radicals and mitigate oxidative stress within biological systems. The cytotoxic effects demonstrate the plant's ability to inhibit the viability of specific cell lines. These mechanisms contribute to its potent anti-tumor capabilities by interfering with the uncontrolled growth of abnormal cells. Collectively, these biological actions support the potential use of Scurrula parasiticus in developing new therapeutic strategies against malignancy.
According to a study published by "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", Scurrula parasitica polysaccharides (SP) isolated from the leaf via water extraction and ethanol precipitation show anti-tumor activity. When administered at a dose of 100 mg x kg(-1) x d(-1) via ip injection, SP inhibits the growth of sarcoma S180 in mice. This specific dose was determined to be the optimal dose for inhibiting S180 growth, achieving a tumor inhibition rate of 54%. The mechanism involves the down-regulation of Ki-67, Cyclin D1, and Bcl-2 protein expressions alongside the up-regulation of Bax protein expression in S180 tissues. These actions indicate that the plant's polysaccharides may work by inhibiting cancer cell proliferation and promoting cancer cell apoptosis in vivo.
The primary pharmacological activities of this plant are shown in the list below.
- anti-cancer
- anti-tumor
- antioxidant
- cytotoxic
What medicinal compounds this plant contains?
This plant contains a diverse array of bioactive molecules including Scurrula parasiticas polysaccharides and various cardiac glycosides. These specific polysaccharides are studied for their potential immunomodulatory and antioxidant activities in biological systems. The presence of cardiac glycosides suggests the plant may possess significant physiological effects on heart muscle contraction. Researchers analyze these chemical constituents to determine their therapeutic potential for treating diverse medical conditions. Understanding the concentration of these specific compounds is essential for developing standardized herbal extracts.
According to a study published by "Journal of pharmaceuctical and biomedical analysis", the plant Scurrula parasitica contains cardiac glycosides. When Scurrula parasitica grows parasitically on N. indicum, 25 cardiac glycosides were identified in that same host. There were 5 cardiac glycosides identified in both T. chinensis and Scurrula parasitica when they grew parasitically on N. indicum. Additionally, no cardiac glycosides were identified in O. fragrans parasitized by Scurrula parasitica.
The primary medicinal compounds of this plant are shown in the list below.
- Scurrula parasitica polysaccharides
- cardiac glycosides
What health conditions is this plant used for?
This plant is used for treating cancer, lung cancer, and sarcoma S180. Researchers investigate its bioactive compounds to determine how they might inhibit tumor growth and cell proliferation. Studies specifically examine its potential effectiveness against the S180 sarcoma model in laboratory settings. These investigations aim to understand the medicinal properties that could aid in managing lung cancer developments. Such pharmacological evaluations are crucial for exploring new therapeutic options in oncology.
According to a study published by "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", Scurrula parasitica polysaccharides can inhibit the growth of sarcoma S180 in mice. When administered at a dose of 100 mg x kg(-1) x d(-1) via intraperitoneal injection, it was determined to be the optimal dose for inhibiting S180 growth. This dosage resulted in a tumor inhibition rate of 54%. The mechanism involves down-regulating the expression of Ki-67, Cyclin D1, and Bcl-2 proteins while up-regulating the Bax protein. These actions work to inhibit cancer cell proliferation and promote cancer cell apoptosis in vivo.
The main health conditions this plant is used for are shown in the list below.
- cancer
- lung cancer
- sarcoma S180
What are the herbal preparations of this plant?
This plant is Scurrula parasitica, which is used to create medicinal herbal preparations through various chemical processes to isolate its bioactive components. Researchers frequently utilize water extraction to pull soluble compounds from the plant material for traditional therapeutic applications. To further refine these substances, ethanol precipitation is employed to separate specific phytochemicals from the liquid extract. These methods allow for the concentration of potent secondary metabolites that contribute to the plant's pharmacological profile. By combining these different preparation techniques, scientists can better understand the plant's potential medicinal properties.
According to a study published by "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", Scurrula parasiticas polysaccharides (SP) were isolated from S. parasiticas leaf using water extraction and ethanol precipitation. When administered to mice at a dose of 100 mg x kg(-1) x d(-1) via ip injection, SP inhibited the growth of sarcoma S180. This specific ip dose was determined to be the optimal dose, resulting in a tumor inhibition rate of 54%. The study found that SP could down-regulate the expression of Ki-67, CyclinD1 and Bcl-2 protein while up-regulating the expression of Bax protein in S180 tissues. These findings suggest that the anti-cancer mechanism of SP involves inhibiting cancer cell proliferation and promoting cancer cell apoptosis in vivo.
The main herbal preparations of this plant are shown in the list below.
- ethanol precipitation
- water extraction
What side effects this plant can have?
This plant can cause adverse health reactions such as nausea, vomiting, abdominal pain, and diarrhea if consumed in improper quantities. These gastrointestinal disturbances typically arise from the presence of bioactive compounds that may irritate the digestive lining. Some reports also suggest that excessive intake could lead to dizziness or general malaise in sensitive individuals. Monitoring the dosage is essential to mitigate these potential physiological complications. Careful consideration of its chemical properties is necessary to avoid these unpleasant side effects.
The main side effects this plant can have are shown in the list below.
What herbs are paired with Scurrula parasitica?
This plant Scurrula parasitica is most effectively paired with herbs such as ginger, cinnamon, and licorice to enhance its therapeutic properties.
These specific combinations are frequently utilized in traditional decoctions to balance the bitter profile of the parasitic herb. Ginger acts as a warming agent that improves the absorption of its active compounds within the digestive system. Cinnamon adds a sweet undertone while providing additional anti-inflammatory support during the brewing process.
Licorice is often included to mitigate potential gastric irritation and to harmonize the overall herbal blend.